Welcome!
It is our honor and pleasure to invite you to The Seventh Annual International Retreat on Applied Immunohistochemistry and Molecular Pathology. Our world-renowned course will take place in Miami, Florida at the [url="http://www.pathlearning.com/Pathology_Learning_Center/Resort.html"]Hyatt Regency- Coral Gables[/url]. The course will run from Sunday, February 3rd, 2013 through Thursday, February 7th, 2013. For the Course Schedule, please click [url="http://www.pathlearning.com/Pathology_Learning_Center/Course_Schedule.html"]here[/url].
The reason we have been offering this retreat for six years (and hopefully many more years to come) is because we maintained focus on the issues that matter the most to the practicing pathologist. In the way of example , the 7th annual retreat will continue to focus on the following aspects of IHC and molecular applications in our practice:
1. Among the >2000 new antibodies, can you offer a short list of new antibodies that I can benefit from their utility in surgical pathology?
2. What type of IHC platform should we bring to our pathology lab?
3. How can we effectively apply QA measures into our IHC lab and molecular lab?
4. What kind of impact do the ASCO/CAP guidelines have on our gross room workflow and documentation?
5. What do I need to do to ensure our lab is compliant with these guidelines, and compliant with other CAP and CLIA requirements?
6. What kind of FISH or molecular assays could our lab benefit from bringing in-house?
7. What are the most common molecular assays in oncologic pathology that I should be familiar with?
8. How do I build a molecular lab in my hospital?
9. Can you show me real - life examples of the staining pattern of antibodies I use in my practice?
10. What are the clinical applications of the molecular oncology assays, and what is the biology behind the testing and treatment?
11. What's the best IHC panel to properly classify lung cancer?
12. What's the best IHC panel to properly work up undifferentiated malignant neoplasm
13. What's the best IHC panel to properly work up metastatic carcinoma of unknown primary site?
13. What's the best IHC panel for mesothelioma vs. carcinoma?
14. How do I workup germ cell tumors by IHC?
15. How do I do IHC on cytology preparations?
16. What are the cancer predictive/prognostic assays that are not based on IHC, ISH or FISH?
17. What are the reimbursement issues facing payments for IHC, FISH and molecular assays?
In essence, there is nothing that you deal with in your day-to-day surgical pathology practice as far as ancillary testing is concerned that is not going to be discussed at this retreat in some way, shape or form. We go straight to the bottom line without presenting to you any non-evidence based science that is not going to affect your practice of surgical pathology.
We constructed the educational program to address the above practical questions, as you can note from perusing the Schedule page. We assembled a group of the most experienced colleagues in the field, including Rich Cartun, Rich Eisen, David Hicks, Todd Barry, Jason Hornick, Savitri Krishnamurthy, and Hadi Yaziji.
On average, 40% of attendees are repeat attendees. Our colleagues who attended the first five courses truly enjoyed this event. In fact, many of them described it as "the most practical CME pathology course I've ever attended". We hope you will enjoy the upcoming course. It is very exciting and we look forward to seeing you there.
This year, the ballroom can only accommodate a maximum of 175 participants in classroom seating. If you have already decided, we recommend that you register as soon as fairly soon to guarantee a spot.
If you have any questions or comments, please do not hesitate to [url="http://www.pathlearning.com/Pathology_Learning_Center/Contact_US.html"]contact us[/url].
Warmest Regards,
Co-Directors
Hadi Yaziji, MD
Richard Eisen, MD
Event details
